SGMO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sangamo Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.074 USD Market Closed

Market Cap: $30.7m

	Sangamo Therapeutics Inc NASDAQ:SGMO	US
I	Incyte Corp F:ICY	US
C	China Financial International Investments Ltd HKEX:721	HK
R	Rio Tinto PLC BMV:RION	UK
	FG Financial Group Inc NASDAQ:FGF	US
W	Westpac Banking Corp SWB:WBC	AU
S	Sun Vending Technology PCL SET:SVT	TH
	Global Menkul Degerler AS IST:GLBMD.E	TR
	Schaffer Corporation Ltd ASX:SFC	AU

Profitability Summary

Sangamo Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-358%

Negative 3Y Average Operating Margin

-449%

Declining Operating Margin

-46% > -358%

Negative Net Margin

-357%

Negative 3Y Average Net Margin

-559%

Declining Net Margin

-91% > -357%

Negative Free Cash Flow Margin

-262%

Negative 3Y Average Free Cash Flow Margin

-366%

Declining Free Cash Flow Margin

-121% > -262%

Exceptional ROE

1.756%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-211%

Declining ROIC

-43% > -440%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.